Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7011373 | 0.88 | — | — | |
| Hydrochloric Acid SCHEMBL7011367 | 0.84 | — | — | |
| SCHEMBL203812 | 0.82 | TSHR (0.33) | TSHRLMNAALDH1A1SMN1; SMN2THRB | |
| SCHEMBL1751456 | 0.78 | ALDH1A1 (0.30) | TSHRLMNAALDH1A1 | |
| SCHEMBL1899483 | 0.78 | ALDH1A1 (0.30) | TSHRLMNAALDH1A1 | |
| SCHEMBL4333058 | 0.76 | ALDH1A1 (0.31) | TSHRALDH1A1 | |
| SCHEMBL28831186 | 0.76 | — | — | |
| SCHEMBL28831243 | 0.76 | CES1 (0.36) | ALDH1A1CES1 | |
| SCHEMBL18421166 | 0.74 | CES1 (0.40) | TSHRALDH1A1CES1MEN1KMT2A | |
| SCHEMBL28831280 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 275 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119518099-A | Additive containing polyfluoroether functional groups and application of additive in battery | 苏州浦昌新能源有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-119431969-A | Method for preparing bathroom pad from nano antibacterial and mildew-proof environment-friendly material | 浙江佳洁塑胶有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-117535841-A | Preparation method of mildew-proof paper-based yarn | 浙江舜浦新材料科技有限公司 | 2024-02-09 | — | — | CN | claimed |
| CN-114933758-A | Quantum dot thin film material with gas-sensitive performance and application thereof | 江苏烨湫传感科技有限公司 | 2022-08-23 | — | — | CN | claimed |
| CN-114540024-A | Perovskite quantum dot material with gas-sensitive property and application thereof | 江苏烨湫传感科技有限公司 | 2022-05-27 | — | — | CN | claimed |
| US-20260078122-A1 | INDAZOLE COMPOUNDS AS PKMYT1 KINASE INHIBITORS | HOFFMANN-LA ROCHE INC. (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4568666-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | Alexion Pharmaceuticals, Inc. (US) | 2025-06-18 | — | — | EP | disclosed |
| US-20250144094-A1 | THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF | ERASCA, INC. | 2025-05-08 | — | — | US | disclosed |
| CN-115515685-B | EIF4E inhibitors and uses thereof | 皮克医疗公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-119768164-A | Pharmaceutical compounds for treating complement-mediated disorders | 阿雷克森制药公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119518099-A | Additive containing polyfluoroether functional groups and application of additive in battery | 苏州浦昌新能源有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-119431969-A | Method for preparing bathroom pad from nano antibacterial and mildew-proof environment-friendly material | 浙江佳洁塑胶有限公司 | 2025-02-14 | — | — | CN | disclosed |
| EP-0807621-A1 | Derivatives of phenylglycine and use thereof as pharmaceuticals | LILLY INDUSTRIES LIMITED (GB) | 1997-11-19 | — | — | EP | disclosed |
| US-5604241-A | Substituted benzylaminoquinuclidines as substance P antagonists | PFIZER INC. (US) | 1997-02-18 | — | — | US | disclosed |
| EP-0665843-A1 | SUBSTITUTED QUINUCLIDINES AS SUBSTANCE P ANTAGONISTS | PFIZER INC. (US) | 1995-08-09 | — | — | EP | disclosed |
| EP-0665844-A1 | SUBSTITUTED BENZYLAMINOQUINUCLIDINES AS SUBSTANCE P ANTAGONISTS | PFIZER INC. (US) | 1995-08-09 | — | — | EP | disclosed |
| WO-1994010170-A1 | SUBSTITUTED QUINUCLIDINES AS SUBSTANCE P ANTAGONISTS | PFIZER INC. (US) | 1994-05-11 | — | — | WO | disclosed |
| WO-1994008997-A1 | SUBSTITUTED BENZYLAMINOQUINUCLIDINES AS SUBSTANCE P ANTAGONISTS | PFIZER INC. (US) | 1994-04-28 | — | — | WO | disclosed |
| US-5258509-A | Catalytic detherification and alkylation | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1993-11-02 | — | — | US | disclosed |
| EP-0430037-A2 | Process for producing 2-carbon-substituted carbapenem derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1991-06-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250144094-A1 | THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF | ULK1, ULK2, ULK3 | TSHR 3373/4885LMNA 4482/4885ALDH1A1 3129/4885 |
| US-20260078122-A1 | INDAZOLE COMPOUNDS AS PKMYT1 KINASE INHIBITORS | PKN3, PKMYT1, IP6K3 | TSHR 2477/4885LMNA 1004/4885ALDH1A1 3032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.